Drug Type Small molecule drug |
Synonyms Acitrel, Omeprazole and Sodium Bicarbonate, Omez Insta + [6] |
Target |
Action inhibitors |
Mechanism ATPase inhibitors(ATPase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (15 Jun 2004), |
Regulation- |
Molecular FormulaC18H21N3NaO6S |
InChIKeyMTVLHMQYMWWRNF-UHFFFAOYSA-N |
CAS Registry774595-73-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
gastric ulcer benign | United States | 30 Aug 2022 | |
Upper gastrointestinal hemorrhage | United States | 30 Aug 2022 | |
Heartburn | United States | 01 Dec 2009 | |
Gastritis | India | 17 May 2008 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Duodenal Ulcer | Phase 1 | United States | 15 Jun 2004 | |
Gastroesophageal Reflux | Phase 1 | United States | 15 Jun 2004 | |
Duodenal Ulcer | Discovery | United States | 15 Jun 2004 | |
Erosive esophagitis | Discovery | United States | 15 Jun 2004 | |
Gastroesophageal Reflux | Discovery | United States | 15 Jun 2004 |
Phase 4 | 91 | (Omeprazole/Sodium Bicarbonate AM Dose) | wejlxfinwf(vhhlewkeak) = ykmjgbgypt cesenafnfd (pesrgsltmz, lbounljwpi - rslsdxgsft) View more | - | 20 Sep 2012 | ||
(Omeprazole/Sodium Bicarbonate PM Dose) | wejlxfinwf(vhhlewkeak) = zygqyfucpq cesenafnfd (pesrgsltmz, gyqbsepbdh - mkvrxnidph) View more |